Company

Profound Medical Corp.

Profound Medical develops incision-free ultrasound ablation systems for prostate conditions.

About

Profound Medical develops ultrasound ablation technology for prostate cancer and benign prostatic hyperplasia. Its TULSA-PRO® system uses real-time MRI imaging to guide treatment. Founded in 2008, the company is based in Mississauga, Canada. In December 2024, it raised USD 35 mn in PIPE funding and is publicly traded.

4Funding rounds

3Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in